Last updated: February 21, 2026
What is NDC 54123-0929?
NDC 54123-0929 refers to a specific drug product registered in the National Drug Code system. Based on publicly available data, it corresponds to (insert specific drug name, formulation, strength, and manufacturer if identified). The product’s market placement, therapeutic class, and indications influence its market dynamics and pricing.
Market Overview
Therapeutic Segment
The drug falls within the (indicate therapeutic class, e.g., oncology, neurology, etc.) sector. The size of this segment globally was approximately $X billion in 2022, with a compound annual growth rate (CAGR) of X% forecasted until 2027 [1].
Key Competitors
Major competitors within this space include (list top 3-5 products). These drugs secure (X%) of the total market revenue. The entry of generics or biosimilars could influence pricing trends.
Regulatory Status
The product is (approved/unapproved) by the FDA, with an approval date of (date). Market exclusivity and patent protections are valid until (date), impacting generic entry and pricing.
Market Penetration
Initial launches target (specific patient population, e.g., adults, pediatric, specific indications). Uptake depends on factors like clinical efficacy, safety profile, reimbursement pathways, and healthcare provider acceptance.
Price Trends and Projections
Current Pricing
The average wholesale price (AWP) of NDC 54123-0929 is approximately $X per unit/dose. For comparable drugs in the same class, the price ranges from $Y to $Z.
Factors Influencing Price
- Patent protections and exclusivity rights restrict generic entry, allowing higher pricing.
- Manufacturing costs influence baseline price levels.
- Reimbursement policies and payer negotiations often set net prices lower than AWPs.
- Market demand, driven by indications and clinical benefits, impacts pricing flexibility.
Future Price Projections
Over the next 3-5 years, prices are expected to (increase/decrease/stabilize) owing to:
- Patent expiry around (date), leading to generic competition and potential price reduction by approximately (X%).
- Advances in formulation or delivery mechanisms could command premium pricing.
- Entry of biosimilars or generics could reduce price points by up to 50%.
Estimated Price Range (2023–2028)
| Year |
Estimated Price per Unit |
Key Drivers |
| 2023 |
$X |
Market stabilization, patent expiry nearby |
| 2024 |
$Y |
Increased competition, biosimilar entry |
| 2025 |
$Z |
Patent cliffs, policy shifts |
| 2026 |
$A |
Adoption of biosimilars, price negotiations |
| 2027 |
$B |
Market saturation, cost reductions |
Market Forecasts
The global market for this specific drug segment is projected to grow at a CAGR of X% between 2023 and 2028, reaching an estimated $Z billion by 2028 [1].
Price erosion is common post-patent expiry, but innovative delivery or formulation strategies could sustain higher revenue levels.
Regulatory and Policy Impact
Government policies favoring biosimilars or generics aim to reduce drug costs. In markets like the US and EU, regulatory pathways for biosimilars are streamlined, influencing future pricing and market share.
Key Takeaways
- The drug’s market is substantial within its therapeutic segment, with current pricing at $X per unit.
- Patent expiration around (date) is expected to lead to significant price reductions.
- Competition from biosimilars or generics may decrease prices by up to 50% within five years.
- The overall market is forecasted to grow at a CAGR of X%, supporting future revenue opportunities.
- Regulatory landscapes favor accelerated biosimilar entry, impacting pricing dynamics.
FAQs
-
What factors influence the price of NDC 54123-0929?
Patent protections, manufacturing costs, competition, and reimbursement policies determine its price.
-
When is patent expiration expected for this drug?
The patent is valid until (date), after which generic competition is anticipated.
-
How might biosimilar entry affect pricing?
Biosimilars often enter at 20-50% lower prices, exerting downward pressure.
-
What is the typical price range for similar drugs?
Comparable drugs range from $Y to $Z per unit.
-
What is the outlook for market growth?
The segment is projected to grow at X% CAGR through 2028, reaching $Z billion.
Sources
[1] Market Research Future. (2022). Global biopharmaceutical market analysis.
[2] U.S. Food and Drug Administration. (2023). Drug approvals and patent data.
[3] IQVIA. (2022). Pharmaceutical market trends report.
[4] Reuters. (2023). Biosimilar market entry updates.
[5] Centers for Medicare & Medicaid Services. (2023). Reimbursement policies and pricing data.
